Nėra interneto ryšio – rodoma išsaugota puslapio versija.

Quest Diagnostics…

USUSD
← Į akcijų filtrą
US:DGXLSE:0KSX

Quest Diagnostics Incorporated (LSE:0KSX) — Medical Specialities. Biržų, kuriose prekiaujama bendrovės akcijomis, skaičius: 2. Šiame puslapyje — kaina ir grafikas, dividendai, didžiausi akcininkai ir akcijų skaičiaus istorija.

Apie įmonę

Svetainė
questdiagnostics.com
Investuotojams
ir.questdiagnostics.com/overview/default.aspx
Sektorius
Health Care · Medical Specialities
Būstinė
Madison, United States
Generalinis direktorius
Steve Rusckowski
Darbuotojai
46 000
Įkurta
1967
Biržoje nuo
29.01.2018 (LSE:0KSX)
Apyvartoje esančios akcijos
110.37 mln. 2026-07-15 duomenimis
Laisvai apyvartinės akcijos
109.81 mln.
Rinkos kapitalizacija
25.21 mlrd. USD
Insaideriai
0.43%
Instituciniai investuotojai
98.9%
Šaka (SIC)
Services-Medical Laboratories
LEI
8MCWUBXQ0WE04KMXBX50
Išmokų santykis
34.2%
FCF
1.35 mlrd. USD
27%
Skola
5.64 mlrd. USD
3.7 m. FCF
Dividendų stažas
22 m.
Pelnas, FCF ir dividendai – už 12 mėnesių iki 30.06.2026 (naujausia įmonės ataskaita).
Aprašymas

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Biržos ir tikeriai

BiržaTikerisValiutaKainaTipas
US USA StocksDGX pagrindinisUSD230.81 +1.65%paprastosios akcijos
LSE London Stock Exchange0KSX IOBUSD231.43 +0.00%paprastosios akcijos

Kaina per 3 mėnesius

kilimo diena kritimo diena dividendų ex data išmokėjimo dataUžveskite / palieskite dieną — atidarymo, uždarymo, aukščiausia ir žemiausia kainos

Dividendai

Per pastaruosius 12 mėnesių, US:DGX: 3.38 USD (4 išm.)

Quest Diagnostics Incorporated (DGX) moka dividendus kas ketvirtį. Per pastaruosius 12 mėnesių buvo sumokėta 3.38 USD už akciją (mokėjimai: 4). Tai sudaro apie 1.46% dabartinės akcijų kainos. Pagal išmokų istoriją kita ex-dividendų data tikėtina apie 05.01.2027. Nepertraukiamų dividendų metai: 22.

Ex dataIšmokaSuma%TipasTikeris
2026-10-062026-10-210.8600 USD0.4/1.5 %kas ketvirtįUS:DGX
2026-07-082026-07-220.8600 USD0.4/1.4 %kas ketvirtįUS:DGX
2026-04-062026-04-200.8600 USD0.4/1.4 %kas ketvirtįUS:DGX
2026-01-132026-01-280.8000 USD0.3/1.4 %kas ketvirtįUS:DGX
2025-10-032025-10-200.8000 USD0.3/≈1.4 %kas ketvirtįUS:DGX
2025-07-072025-07-210.8000 USD0.3/≈1.4 %kas ketvirtįUS:DGX
2025-04-072025-04-210.8000 USD0.3/≈1.4 %kas ketvirtįUS:DGX
2025-01-142025-01-290.7500 USD0.3/≈1.3 %kas ketvirtįUS:DGX

Šios savaitės naujienos

Naujienų iš įmonės svetainės kol kas nėra.

reklama

Didžiausi akcininkai

TurėtojasDalisAkcijosAtaskaitos data
Blackrock Inc.8.4%9.28 mln.2026-06-30
Vanguard Capital Managem…6.55%7.23 mln.2026-06-30
Vanguard Portfolio Manag…5.55%6.13 mln.2026-06-30
State Street Corporation5%5.52 mln.2026-06-30
Price (T.Rowe) Associate…4.93%5.44 mln.2026-06-30
Boston Partners4.3%4.74 mln.2026-06-30
JPMORGAN CHASE & CO3.19%3.52 mln.2026-06-30
VANGUARD INDEX FUNDS-Van…3.18%3.51 mln.2026-06-30
Geode Capital Management…2.84%3.14 mln.2026-06-30
VANGUARD INDEX FUNDS-Van…2.6%2.87 mln.2026-06-30
Morgan Stanley2.23%2.46 mln.2026-06-30
VANGUARD INDEX FUNDS-Van…2.17%2.4 mln.2026-06-30
Edgepoint Investment Gro…2.04%2.25 mln.2026-06-30
iShares Trust-iShares Co…1.33%1.47 mln.2026-08-31
Fidelity Concord Street…1.3%1.43 mln.2026-07-31
SPDR S&P 500 ETF TRUST-S…1.23%1.36 mln.2026-08-31
John Hancock Funds III-D…1.09%1.2 mln.2026-07-31
JPMorgan Trust II-JPMorg…1.04%1.15 mln.2026-06-30
T. Rowe Price Dividend G…1%1.11 mln.2026-06-30
John Hancock Funds III-D…0.96%1.06 mln.2026-07-31
DAVIS J E CAUSEY (Chief…≈0.13%142 4232026-03-04
DAVIS JAMES E (Chief Exe…≈0.11%122 4232026-09-01
DOHERTY CATHERINE T (Off…≈0.06%71 6242026-03-05
PREVOZNIK MICHAEL E (Gen…≈0.04%42 3372026-08-28
DEPPE MICHAEL J (Officer…≈0.03%35 1962026-03-04
SAMAD SAMER ABDUL (Chief…≈0.03%33 4782026-07-22
RING TIMOTHY M (Director…≈0.03%31 1402026-05-20
PFEIFFER GARY M (Directo…≈0.03%31 0052026-05-20
MAIN TIMOTHY L (Director…≈0.02%27 4602026-07-22
GREGG VICKY B (Director)≈0.02%18 3862026-07-22